See what’s trending right now
Measles outbreaksin Health
4 hours agoU.S. measles cases surge to a 33-year high, marking the worst outbreak in decades as health officials raise alarms.
Health
Can (and should) we cure blindness?
neutralHealth
This thought-provoking piece follows comedian Tom Skelton’s personal journey with vision loss as he wrestles with a bigger question: While science is making huge strides in restoring eyesight—from bionic eyes to gene therapy—should society frame blindness as a "problem" to fix? The article doesn’t just celebrate medical breakthroughs; it challenges assumptions about disability, identity, and what we consider "normal."
Editor’s Note: Beyond the cool science, this story taps into a deeper debate—one that’s especially relevant as tech like neural implants and CRISPR advance. It’s about who gets to decide what needs "curing" and whether progress should focus solely on medical fixes or also on inclusivity. For millions with disabilities, that distinction isn’t academic—it shapes how they’re seen by the world (and themselves).
Why World Pulse Now?
Global Coverage
All major sources, one page
Emotional Lens
Feel the mood behind headlines
Trending Topics
Know what’s trending, globally
Read Less, Know More
Get summaries. Save time
Stay informed, save time
Learn moreLive Stats
Articles Processed
9,173
Trending Topics
125
Sources Monitored
211
Last Updated
3 hours ago
Live data processing
How it works1-Minute Daily Briefing
Stay sharp in 60 seconds. Get concise summaries of today’s biggest stories — markets, tech, sports, and more
Why World Pulse Now?
Global Coverage
All major sources, one page
Emotional Lens
Feel the mood behind headlines
Trending Topics
Know what’s trending, globally
Read Less, Know More
Get summaries. Save time
Stay informed, save time
Learn moreLive Stats
Articles Processed
9,173
Trending Topics
125
Sources Monitored
211
Last Updated
3 hours ago
Live data processing
How it works1-Minute Daily Briefing
Stay sharp in 60 seconds. Get concise summaries of today’s biggest stories — markets, tech, sports, and more